Case Report

Vankomisin tedavisine bağlı olarak red neck sendromu gelişen penisiline dirençli pnömokok menenjiti olgusu

Volume: 2 Number: 1 January 25, 2019
  • Hüseyin Esmer
  • Salih Cesur *
  • Çiğdem Ataman Hatipoğlu
  • Esra Kaya Kılıç
  • Sami Kınıklı
  • Güler Vahaboğlu
EN TR

Vankomisin tedavisine bağlı olarak red neck sendromu gelişen penisiline dirençli pnömokok menenjiti olgusu

Abstract

Vankomisine bağlı olarak gelişen yan etkilerden red neck (kırmızı boyun) sendromu histamin aşırı salınımına bağlı bazen hayatı tehdit edebilen bir komplikasyondur. Red neck sendromu gelişen hastalarda zorunlu hallerde kortikosterod ve antihistaminiklerle birlikte vankomisin tedavisine devam edilebilir veya alternatif bir antibiyotik tedavisine geçilebilir. Bu yazıda, penisiline dirençli pnömokok menenjiti tanısıyla vankomisin tedavisi başlanan ve tedavinin 8. gününde red neck sendromu gelişen 54 yaşında bir kadın hasta sunuldu. Hastanın o sabah verilen vankomisin infüzyonunun bir saatten kısa sürdüğü öğrenildi.  Hastanın vankomisin tedavisi kesilerek intravenöz linezolid tedavisine geçildi.

Sonuç olarak, vankomisinin hızlı infüzyonuna bağlı olarak red neck sendromu gelişebilir ve bu olgularda tedavi yönetiminde alternatif ilaç olarak linezolid kullanılabilir. 

Keywords

References

  1. 1. Ulusoy S. Dirençli pnömokok infeksiyonlarında antimikrobiyal ilaç seçimi. Flora 2003; 8: 22-6.
  2. 2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 20thInformational Supplement, 2010, M100-S20. CLSI, Wayne, PA.
  3. 3. Edward N. Janoff and Daniel M. Musher. Streptococcus pneumoniae. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th Edition, 2015; 201: 2310-27.e5.
  4. 4. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice Guidelines for the Management of Bacterial Meningitis. Clinical Infectious Diseases 2004; 39: 1267-84.
  5. 5. Martel TJ, Whitten RA. Red Man Syndrome. Treasure Island (FL): Stat Pearls Publishing; 2018-.www.ncbi.nlm.nih.gov/pubmed/29494112.
  6. 6. Sivagnanam S and Deleu D. Red man syndrome. Crit Care 2003; 7: 119-20.
  7. 7. Polk RE, Healy DP, Schwartz LB, Rock DT, Garson ML, Roller K. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis 1988; 157: 502-7.
  8. 8. Cheung RP, DiPiro JT. Vancomycin: an update. Pharmacotherapy 1986; 6: 153-69.

Details

Primary Language

Turkish

Subjects

Health Care Administration

Journal Section

Case Report

Authors

Hüseyin Esmer This is me

Çiğdem Ataman Hatipoğlu This is me

Esra Kaya Kılıç This is me

Sami Kınıklı This is me

Güler Vahaboğlu This is me

Publication Date

January 25, 2019

Submission Date

October 16, 2018

Acceptance Date

November 29, 2018

Published in Issue

Year 2019 Volume: 2 Number: 1

APA
Esmer, H., Cesur, S., Ataman Hatipoğlu, Ç., Kaya Kılıç, E., Kınıklı, S., & Vahaboğlu, G. (2019). Vankomisin tedavisine bağlı olarak red neck sendromu gelişen penisiline dirençli pnömokok menenjiti olgusu. Journal of Health Sciences and Medicine, 2(1), 34-37. https://doi.org/10.32322/jhsm.471102
AMA
1.Esmer H, Cesur S, Ataman Hatipoğlu Ç, Kaya Kılıç E, Kınıklı S, Vahaboğlu G. Vankomisin tedavisine bağlı olarak red neck sendromu gelişen penisiline dirençli pnömokok menenjiti olgusu. J Health Sci Med / JHSM. 2019;2(1):34-37. doi:10.32322/jhsm.471102
Chicago
Esmer, Hüseyin, Salih Cesur, Çiğdem Ataman Hatipoğlu, Esra Kaya Kılıç, Sami Kınıklı, and Güler Vahaboğlu. 2019. “Vankomisin Tedavisine Bağlı Olarak Red Neck Sendromu Gelişen Penisiline Dirençli Pnömokok Menenjiti Olgusu”. Journal of Health Sciences and Medicine 2 (1): 34-37. https://doi.org/10.32322/jhsm.471102.
EndNote
Esmer H, Cesur S, Ataman Hatipoğlu Ç, Kaya Kılıç E, Kınıklı S, Vahaboğlu G (January 1, 2019) Vankomisin tedavisine bağlı olarak red neck sendromu gelişen penisiline dirençli pnömokok menenjiti olgusu. Journal of Health Sciences and Medicine 2 1 34–37.
IEEE
[1]H. Esmer, S. Cesur, Ç. Ataman Hatipoğlu, E. Kaya Kılıç, S. Kınıklı, and G. Vahaboğlu, “Vankomisin tedavisine bağlı olarak red neck sendromu gelişen penisiline dirençli pnömokok menenjiti olgusu”, J Health Sci Med / JHSM, vol. 2, no. 1, pp. 34–37, Jan. 2019, doi: 10.32322/jhsm.471102.
ISNAD
Esmer, Hüseyin - Cesur, Salih - Ataman Hatipoğlu, Çiğdem - Kaya Kılıç, Esra - Kınıklı, Sami - Vahaboğlu, Güler. “Vankomisin Tedavisine Bağlı Olarak Red Neck Sendromu Gelişen Penisiline Dirençli Pnömokok Menenjiti Olgusu”. Journal of Health Sciences and Medicine 2/1 (January 1, 2019): 34-37. https://doi.org/10.32322/jhsm.471102.
JAMA
1.Esmer H, Cesur S, Ataman Hatipoğlu Ç, Kaya Kılıç E, Kınıklı S, Vahaboğlu G. Vankomisin tedavisine bağlı olarak red neck sendromu gelişen penisiline dirençli pnömokok menenjiti olgusu. J Health Sci Med / JHSM. 2019;2:34–37.
MLA
Esmer, Hüseyin, et al. “Vankomisin Tedavisine Bağlı Olarak Red Neck Sendromu Gelişen Penisiline Dirençli Pnömokok Menenjiti Olgusu”. Journal of Health Sciences and Medicine, vol. 2, no. 1, Jan. 2019, pp. 34-37, doi:10.32322/jhsm.471102.
Vancouver
1.Hüseyin Esmer, Salih Cesur, Çiğdem Ataman Hatipoğlu, Esra Kaya Kılıç, Sami Kınıklı, Güler Vahaboğlu. Vankomisin tedavisine bağlı olarak red neck sendromu gelişen penisiline dirençli pnömokok menenjiti olgusu. J Health Sci Med / JHSM. 2019 Jan. 1;2(1):34-7. doi:10.32322/jhsm.471102

Cited By

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912

Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.